Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @bbglab
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @bbglab
-
Prikvačeni tweet
Latest paper from the lab "Systematic analysis of alterations in the ubiquitin proteolysis system in Cancer" at
@NatureCancer. By@fran_mj88,@fmuinos,@erika_loar,@nlbigas and Abel Gonzalez-Perez. Here a twitter summary:https://twitter.com/fran_mj88/status/1201805685647904768 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our Group Leader
@nlbigas awarded with the "Diz Pintado" National Cancer Research Award for her contributions to Oncology Research. Thank you@CICancer_com and@usal for the recognition!!pic.twitter.com/X94t5PYnKJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today our Group Leader gives a seminar at CNIO.https://twitter.com/CNIO_Cancer/status/1220356188019351552 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Out as preprint the work done by
@pepeb_5 on a novel non-parametric method to cluster individual cells into clones based on their mutation profiles. A good collaboration resulting from the@ITN_CONTRA project secondment.https://bit.ly/2Rt4ujEHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
bbglab proslijedio/la je Tweet
Really excited to share our latest work on a novel non-parametric method to cluster individual cells into clones based on their mutation profiles. Here’s a little bit of explanation about our new method, named BnpC. (1/6)https://www.biorxiv.org/content/10.1101/2020.01.15.907345v1?rss=1 …
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
bbglab proslijedio/la je Tweet
The first issue of
@NatureCancer is out today. Proud that our lab has contributed one paper in it https://www.nature.com/articles/s43018-019-0001-2 …pic.twitter.com/VeP3bAPsLv
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
bbglab proslijedio/la je Tweet
Dr Núria López-Bigas, ICREA Research Professor at the Institute for Research in Biomedicine of The Barcelona Institute of Science & Technology, Barcelona, , spoke at IARC about the mutational footprints of cancer therapies. Watch her presentation https://www.iarc.fr/video/the-mutational-footprints-of-cancer-therapies/ …pic.twitter.com/36p1jKP96A
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
"OncodriveCLUSTL: a clustering method to identify cancer drivers" presented by
@clarnedo today at#JBG2019.pic.twitter.com/nv1gveI1VU
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
bbglab proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
bbglab proslijedio/la je Tweet
Very happy lab indeed!https://twitter.com/bbglab/status/1205169654609649664 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
#AdvCompBio@clarnedo presenting oncodriveCLUSTL at Advances on Computational Biology conferencepic.twitter.com/bAd70CU9lE
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
bbglab proslijedio/la je Tweet
#AdvCompBio starting with an introduction from the three chairs@nlbigas@jfkelso and Alison Kennedy#lapedrera#WomenInScience#WomenInSTEMpic.twitter.com/cXJ5isiGdU
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today our Group Leader
@nlbigas presenting the work done by the Research Integrity Committee at@IRBBarcelona. One of the main messages: TRUST is key.pic.twitter.com/8kSTX2L9ub
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
bbglab proslijedio/la je Tweet
«El estudio ayudará a entender mejor los efectos a largo plazo de algunas quimioterapias», comenta @erika_loar, investigadora del@IRBBarcelona en el@bbglab, en relación a su proyecto financiado por la@aecc_es en esta entrevista en@TribunaAlbacete
https://bit.ly/37th89h pic.twitter.com/4dftTrRi3e
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
bbglab proslijedio/la je Tweet
A very under-studied yet important consequence of
#cancer therapies: the mutations they induce https://www.nature.com/articles/s41588-019-0525-5 …@NatureGenet by@nlbigas@oriol_pich@fmuinos@IRBBarcelona and their colleaguespic.twitter.com/4Dsyy7z2tg
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
bbglab proslijedio/la je Tweet
Our paper on “The Mutational Footprints of Cancer Therapies” is out in
@NatureGenet. https://www.nature.com/articles/s41588-019-0525-5 …pic.twitter.com/pFMc0zSITU
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today was the last day of Loris Mularoni at
@bbglab at@IRBBarcelona. He will work at@cmrb from Monday. Best wishes for Loris on this new exciting position. We will miss you.pic.twitter.com/5WL8gdKLgh
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Almost half of our team have participated at
#EMBLCanGen!!!!@nlbigas as co-organizer and speaker.@fran_mj88 giving a talk; and@clarnedo ,@hania_kranas ,@inesentis ,@pepeb_5 ,@oriol_pich ,@fmuinos ,@Frigola_Joan , Santiago Gonzalez and Abel Gonzalez presenting posters.pic.twitter.com/dhXXSBvfgp
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
bbglab proslijedio/la je Tweet
Very happy to announce a major IntOGen update. This new version contains a comprehensive and reliable compendium of cancer genes and their mutational features across 61 tumour types, obtained by analysing 26,955 cancer genomes http://www.intogen.org . Thread
pic.twitter.com/QXd4mGkqVu
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
